Skip to main content
. 2025 Feb 17;25:88. doi: 10.1186/s12876-025-03674-9

Table 3.

Factors associated with minimal hepatic encephalopathy in cirrhotic patients

Univariate analysis Multivariable analysis
OR (95% CI) P value OR (95% CI) P value
Age, year 1.08 (1.03–1.13) 0.001 1.08 (1.02–1.13) 0.005
Female gender 1.73 (0.85–3.54) 0.132
Education level
Primary school reference
High school 0.36 (0.16–0.82) 0.016
University 0.28 (0.11–0.72) 0.009
Anthropometric data
Body mass index, kg/m2 0.98 (0.91–1.06) 0.666
Waist circumference, cm 0.99 (0.96–1.02) 0.812
Hip circumference, cm 0.99 (0.97–1.03) 0.994
Body fat, kg 0.99 (0.96–1.03) 0.908
Visceral fat level 1.02 (0.95–1.10) 0.518
Muscle mass, kg 0.92 (0.85–0.98) 0.018
Whole body phase angle 0.42 (0.24–0.72) 0.002
Sarcopenia 3.12 (1.49–6.56) 0.003 3.29 (1.44–7.50) 0.005
Etiology of cirrhosis
Hepatitis B virus 0.68 (0.32–1.41) 0.298
Hepatitis C virus 0.97 (0.46–2.04) 0.935
Alcohol 0.84 (0.18–3.97) 0.827
Comorbidity
Type 2 diabetes mellitus 1.05 (0.50–2.20) 0.905
Hypertension 0.58 (0.28–1.19) 0.140
Hypercholesterolemia 0.72 (0.33–1.56) 0.404
Chronic pulmonary disease 1.18 (0.24–5.79) 0.840
Thyroid disease 2.85 (0.98–8.28) 0.054
Extrahepatic malignancy 0.65 (0.14–2.99) 0.579
Hepatocellular carcinoma 1.17 (0.58–2.38) 0.663
History of decompensation
Ascites 1.69 (0.66–4.33) 0.275
Overt hepatic encephalopathy 5.00 (0.97–25.83) 0.055 7.40 (1.20-45.56) 0.031
Variceal hemorrhage 3.29 (1.58–6.85) 0.001 3.13 (1.38–7.10) 0.006
Medication use
Nonselective beta-blockers 1.18 (0.51–2.72) 0.695
Diuretics 0.77 (0.16–3.58) 0.735
Statins 0.82 (0.38–1.77) 0.609
MELD score 1.07 (0.92–1.24) 0.376
CTP score 1.38 (0.85–2.24) 0.194
Liver stiffness ≥ 25 kPa 2.18 (1.04–4.55) 0.039
Mini-mental state examination score 0.77 (0.62–0.96) 0.021
PSQI score 1.05 (0.96–1.16) 0.296
BARB score
Low risk (< 0) Reference
Intermediate risk (0–20) 2.07 (0.91–4.68) 0.082
High risk (> 20) 2.18 (0.54–8.85) 0.274

Abbreviations: CI, confidence interval; CTP, Child-Turcotte-Pugh; PSQI, HBV, hepatitis B virus; HCV, hepatitis C virus; MELD, Model for End-Stage Liver Disease; OR, odds ratio; PSQI, Pittsburgh sleep quality index